Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
310 rows where has_known_aptamer = 1, in_cev_map = 0 and surface_class = "B_cargo" sorted by evidence_priority descending
This data as json, CSV (advanced)
surface_class 1
- B_cargo · 310 ✖
in_cev_map 1
- - · 310 ✖
has_known_aptamer 1
- 1 · 310 ✖
has_activation_state_pdb_pair 1
- 0 310
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P00439 | PAH | Phenylalanine-4-hydroxylase | Tier 1 | 0.618 | 1 | B_cargo | 20 | 88.69 | 0 | 0 | 1 | 11 | 39435559, 35394406, 35081018, 34973551, 33386219, 32587339, 31349094, 26043089, 24749544, 23583275, 16914451 | 0 | phenylketonuria | 0.892702971437507 | ||
| P40337 | VHL | von Hippel-Lindau disease tumor suppressor | Tier 1 | 0.616 | 1 | B_cargo | 100 | 84.44 | 0 | 0 | 1 | 5 | 39437434, 36250201, 34549489, 23142634, 17290195 | 0 | von Hippel-Lindau disease | 0.8883247767048489 | ||
| Q13315 | ATM | Serine-protein kinase ATM | Tier 1 | 0.613 | 1 | B_cargo | 14 | 1 | 0 | 1 | 9 | 41867498, 39253616, 37656667, 34733968, 28838608, 28706912, 26176230, 17386435, 15181173 | 0 | ataxia telangiectasia | 0.8759719859489208 | |||
| P22304 | IDS | Iduronate 2-sulfatase | Tier 1.5 | 0.613 | 1 | B_cargo | 2 | 93.06 | 0 | 0 | 1 | 9 | 41791433, 41521476, 41396069, 40394224, 37948569, 31273548, 30529550, 28420169, 20842131 | 0 | mucopolysaccharidosis type 2 | 0.8781523206667287 | ||
| P35670 | ATP7B | Copper-transporting ATPase 2 | Tier 1 | 0.61 | 1 | B_cargo | 13 | 71.69 | 1 | 0 | 1 | 1 | 39737993 | 0 | Wilson disease | 0.8657500553466239 | ||
| O14746 | TERT | Telomerase reverse transcriptase | Tier 1 | 0.607 | 1 | B_cargo | 23 | 80.19 | 1 | 0 | 1 | 13 | 41104418, 40347637, 40062394, 39513874, 39441744, 37427434, 36005058, 35658460, 33476148, 28004350, 24176970, 22013508 | 0 | dyskeratosis congenita, autosomal dominant 2 | 0.8577919827748599 | ||
| P04629 | NTRK1 | High affinity nerve growth factor receptor | Tier 1 | 0.607 | 1 | B_cargo | 65 | 78.25 | 0 | 0 | 1 | 1 | 38604287 | 0 | hereditary sensory and autonomic neuropathy type 4 | 0.8579248191890114 | ||
| Q9BZS1 | FOXP3 | Forkhead box protein P3 | Tier 1 | 0.606 | 1 | B_cargo | 2 | 56.72 | 0 | 0 | 1 | 8 | 40448637, 34457999, 32892748, 26999456, 24460675, 22323540, 18698484, 18319343 | 0 | immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome | 0.8516802661294931 | ||
| P19544 | WT1 | Wilms tumor protein | Tier 1 | 0.606 | 1 | B_cargo | 28 | 50.78 | 0 | 0 | 1 | 3 | 27417971, 19123921, 11329270 | 0 | Denys-Drash syndrome | 0.8525486743466777 | ||
| P37231 | PPARG | Peroxisome proliferator-activated receptor gamma | Tier 1 | 0.605 | 1 | B_cargo | 100 | 76.12 | 0 | 0 | 1 | 3 | 37203464, 33671292, 28206680 | 0 | type 2 diabetes mellitus | 0.8486094742593474 | ||
| Q9Y6K1 | DNMT3A | DNA (cytosine-5)-methyltransferase 3A | Tier 1 | 0.605 | 1 | B_cargo | 43 | 72.94 | 1 | 0 | 1 | 3 | 39079576, 31733056, 23179556 | 0 | acute myeloid leukemia | 0.8505245588442946 | ||
| P54132 | BLM | RecQ-like DNA helicase BLM | Tier 1 | 0.605 | 1 | B_cargo | 15 | 60.53 | 0 | 0 | 1 | 9 | 40700985, 38959435, 34973563, 33571410, 33050386, 31563064, 30343567, 27332117, 19146404 | 0 | Bloom syndrome | 0.8491084997646711 | ||
| Q92574 | TSC1 | Hamartin | Tier 1 | 0.604 | 1 | B_cargo | 5 | 62.06 | 1 | 0 | 1 | 1 | 18974095 | 0 | tuberous sclerosis | 0.8476796313298992 | ||
| Q92793 | CREBBP | CREB-binding protein | Tier 1 | 0.603 | 1 | B_cargo | 100 | 52.53 | 0 | 0 | 1 | 1 | 39429683 | 0 | Rubinstein-Taybi syndrome due to CREBBP mutations | 0.8442311239876018 | ||
| P58012 | FOXL2 | Forkhead box protein L2 | Tier 1.5 | 0.603 | 1 | B_cargo | 2 | 60.12 | 0 | 0 | 1 | 1 | 37933840 | 0 | blepharophimosis, ptosis, and epicanthus inversus syndrome | 0.841709236718747 | ||
| P38398 | BRCA1 | Breast cancer type 1 susceptibility protein | Tier 1 | 0.602 | 1 | B_cargo | 33 | 41.59 | 1 | 0 | 1 | 13 | 40251554, 37288783, 36858016, 32945515, 32245065, 29737162, 28841982, 26784987, 24734899, 23836560, 21800393, 16825284 | 0 | breast cancer | 0.839035109761358 | ||
| P20823 | HNF1A | Hepatocyte nuclear factor 1-alpha | Tier 1.5 | 0.602 | 1 | B_cargo | 6 | 56.97 | 0 | 0 | 1 | 4 | 15781225, 15629461 | 0 | MODY | 0.8405262466243777 | ||
| O43435 | TBX1 | T-box transcription factor TBX1 | Tier 1.5 | 0.602 | 1 | B_cargo | 1 | 68.19 | 0 | 0 | 1 | 1 | 24797903 | 0 | 22q11.2 deletion syndrome | 0.8406035626999856 | ||
| Q02127 | DHODH | Dihydroorotate dehydrogenase (quinone), mitochondrial | Tier 1 | 0.6 | 1 | B_cargo | 100 | 96.12 | 0 | 0 | 1 | 1 | 29626096 | 0 | postaxial acrofacial dysostosis | 0.8330628404263816 | ||
| Q5S007 | LRRK2 | Leucine-rich repeat serine/threonine-protein kinase 2 | Tier 1 | 0.6 | 1 | B_cargo | 44 | 77.5 | 1 | 0 | 1 | 4 | 38467937, 37586882, 37422510, 36774388 | 0 | Hereditary late-onset Parkinson disease | 0.8349742982582067 | ||
| Q15910 | EZH2 | Histone-lysine N-methyltransferase EZH2 | Tier 1 | 0.6 | 1 | B_cargo | 38 | 76.25 | 1 | 0 | 1 | 8 | 41574287, 41223251, 40931580, 39853766, 36626902, 32884286, 30795863, 27719642 | 0 | Weaver syndrome | 0.8324078192564933 | ||
| P49715 | CEBPA | CCAAT/enhancer-binding protein alpha | Tier 1 | 0.6 | 1 | B_cargo | 2 | 61.69 | 0 | 0 | 1 | 7 | 38965606, 30909853, 31546149, 30795863, 28639199, 26983359 | 0 | acute myeloid leukemia | 0.8336701187896877 | ||
| Q05066 | SRY | Sex-determining region Y protein | Tier 1.5 | 0.599 | 1 | B_cargo | 10 | 67.62 | 1 | 0 | 1 | 1 | 40082426 | 0 | 46,XY sex reversal 1 | 0.8290523705747719 | ||
| P41235 | HNF4A | Hepatocyte nuclear factor 4-alpha | Tier 1 | 0.598 | 1 | B_cargo | 8 | 73.88 | 0 | 0 | 1 | 1 | 37016361 | 0 | MODY | 0.8258786338560885 | ||
| Q14191 | WRN | Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN | Tier 1 | 0.598 | 1 | B_cargo | 42 | 68.62 | 0 | 0 | 1 | 1 | 27332117 | 0 | Werner syndrome | 0.8278730962406992 | ||
| O94761 | RECQL4 | ATP-dependent DNA helicase Q4 | Tier 1 | 0.598 | 1 | B_cargo | 2 | 67.38 | 0 | 0 | 1 | 1 | 31495919 | 0 | Rothmund-Thomson syndrome type 2 | 0.8261878622968941 | ||
| Q9H3D4 | TP63 | Tumor protein 63 | Tier 1 | 0.598 | 1 | B_cargo | 26 | 63.19 | 0 | 0 | 1 | 1 | 17563751 | 0 | ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 | 0.8281511708882607 | ||
| P48431 | SOX2 | Transcription factor SOX-2 | Tier 1 | 0.598 | 1 | B_cargo | 13 | 59.84 | 1 | 0 | 1 | 13 | 41377018, 40082426, 37891174, 37370863, 36284815, 34405338, 31991109, 31301870, 28988933, 26176230, 23892456, 18490265, 15863505 | 0 | anophthalmia/microphthalmia-esophageal atresia syndrome | 0.8263477268235936 | ||
| Q13485 | SMAD4 | SMAD family member 4 | Tier 1.5 | 0.598 | 1 | B_cargo | 12 | 73.38 | 0 | 0 | 1 | 10 | 39602246, 35356877, 33124760, 32456365, 31876518, 29632714, 27843907, 21266541, 17132729, 16775010 | 0 | juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome | 0.8277625447220475 | ||
| P13686 | ACP5 | Tartrate-resistant acid phosphatase type 5 | Tier 1.5 | 0.597 | 1 | B_cargo | 2 | 94.62 | 0 | 0 | 1 | 2 | 30537181 | 0 | Spondyloenchondrodysplasia with immune dysregulation | 0.8234579245679164 | ||
| Q9BYX4 | IFIH1 | Interferon-induced helicase C domain-containing protein 1 | Tier 1.5 | 0.597 | 1 | B_cargo | 9 | 79.44 | 1 | 0 | 1 | 1 | 18983163 | 0 | Aicardi-Goutieres syndrome 7 | 0.8235229759148853 | ||
| Q8NB91 | FANCB | Fanconi anemia group B protein | Tier 1 | 0.596 | 1 | B_cargo | 6 | 71.0 | 1 | 0 | 1 | 1 | 23836560 | 0 | Fanconi anemia | 0.8195998375932156 | ||
| Q9NZJ4 | SACS | Sacsin | Tier 1 | 0.595 | 1 | B_cargo | 7 | 0 | 0 | 1 | 5 | 41610745, 40771130, 39719055, 33584503 | 0 | Autosomal recessive spastic ataxia of Charlevoix-Saguenay | 0.8179172286536236 | |||
| P49638 | TTPA | Alpha-tocopherol transfer protein | Tier 1 | 0.594 | 1 | B_cargo | 6 | 94.12 | 0 | 0 | 1 | 20 | 41699153, 41371773, 38963794, 36882463, 36203210, 35563278, 33918821, 31870256, 30197987, 30015643, 28051346, 26876003, 25855589, 24922319, 21142878, 20594164, 20387790, 20050927, 19485299, 18713263 | 0 | Ataxia with vitamin E deficiency | 0.8129089189782969 | ||
| P61244 | MAX | Protein max | Tier 1 | 0.593 | 1 | B_cargo | 12 | 81.31 | 1 | 0 | 1 | 288 | 41934996, 41833970, 41619462, 41469028, 41439640, 41422825, 41237904, 41213249, 41083647, 41002303, 40921876, 40905551, 40902004, 40864593, 40850274, 40840129, 40642767, 40491004, 40383336, 40356230, 40164941, 40097648, 40011207, 39923524, 39890743, 39852074, 39828650, 39630145, 39605530, 39566329, 39420595, 39360861, 39225197, 39117896, 39115976, 39103298, 39056617, 38968658, 38920574, 38907914, 38899396, 38846799, 38682443, 38573322, 38542416, 38385442, 38359718, 38348887, 38217658, 38103284 | 0 | pheochromocytoma | 0.8086574254358271 | ||
| P04198 | MYCN | N-myc proto-oncogene protein | Tier 1.5 | 0.593 | 1 | B_cargo | 2 | 60.16 | 0 | 0 | 1 | 3 | 38074684, 34703655, 23243020 | 0 | Feingold syndrome type 1 | 0.8115451687313872 | ||
| Q9NZC2 | TREM2 | Triggering receptor expressed on myeloid cells 2 | Tier 1 | 0.592 | 1 | B_cargo | 15 | 76.75 | 0 | 0 | 1 | 5 | 39695715, 35147513, 35144252 | 0 | Nasu-Hakola disease | 0.8076185000216165 | ||
| Q09472 | EP300 | Histone acetyltransferase p300 | Tier 1 | 0.591 | 1 | B_cargo | 60 | 53.25 | 1 | 0 | 1 | 2 | 39429683, 28539359 | 0 | Rubinstein-Taybi syndrome due to EP300 haploinsufficiency | 0.8025866884926094 | ||
| Q03164 | KMT2A | Histone-lysine N-methyltransferase 2A | Tier 1 | 0.591 | 1 | B_cargo | 60 | 1 | 0 | 1 | 1 | 33606679 | 0 | Wiedemann-Steiner syndrome | 0.802084366673722 | |||
| P51530 | DNA2 | DNA replication ATP-dependent helicase/nuclease DNA2 | Tier 1.5 | 0.591 | 1 | B_cargo | 1 | 87.81 | 0 | 0 | 1 | 79 | 41919953, 40756646, 40549055, 40280078, 40067128, 39933341, 39701233, 39400726, 39339485, 39263860, 39196429, 38844882, 38240894, 38219326, 38057050, 38015452, 37991343, 37955623, 37604608, 37499488, 37470836, 36958207, 36809725, 36242904, 36178489, 36150338, 35491044, 35384954, 35176850, 35093773, 33676715, 33496853, 33415103, 33217231, 32800122, 32601890, 32475386, 32200901, 31706177, 31561796, 31278549, 31276907, 31159934, 30952252, 30904620, 30862445, 30609356, 30209628, 30172325, 29884355 | 0 | mitochondrial DNA deletion syndrome with progressive myopathy | 0.8039462281320306 | ||
| P28329 | CHAT | Choline O-acetyltransferase | Tier 1 | 0.59 | 1 | B_cargo | 7 | 83.94 | 0 | 0 | 1 | 1 | 38780008 | 0 | Congenital myasthenic syndromes | 0.80158576006834 | ||
| Q9NRG9 | AAAS | Aladin | Tier 1.5 | 0.59 | 1 | B_cargo | 2 | 75.25 | 1 | 0 | 1 | 2 | 39798364, 30768874 | 0 | triple-A syndrome | 0.8009946434571534 | ||
| P17735 | TAT | Tyrosine aminotransferase | Tier 1.5 | 0.59 | 1 | B_cargo | 1 | 91.75 | 0 | 0 | 1 | 116 | 42052694, 41392711, 41107360, 41026857, 40789888, 40681131, 40125796, 40063097, 39876991, 39558155, 39335496, 39318271, 39167715, 38924638, 38501479, 38054213, 37240414, 36879476, 36832059, 36642821, 36576612, 36475447, 36277654, 36209487, 36198145, 35654302, 35364795, 33981364, 33909408, 33155468, 33149582, 32976590, 32250590, 32147886, 32100315, 32061015, 32051269, 31975549, 31881749, 31880928, 31707021, 35345244, 31243610, 30976173, 30540162, 30529550, 30350592, 30285239, 30198708, 29464116 | 0 | tyrosinemia type II | 0.7986496109306669 | ||
| Q9NUX5 | POT1 | Protection of telomeres protein 1 | Tier 1 | 0.589 | 1 | B_cargo | 14 | 87.38 | 1 | 0 | 1 | 3 | 41867726, 25934589, 21772997 | 0 | tumor predisposition syndrome 3 | 0.7983039512174813 | ||
| Q9UMX1 | SUFU | Suppressor of fused homolog | Tier 1 | 0.589 | 1 | B_cargo | 10 | 82.31 | 0 | 0 | 1 | 1 | 18698484 | 0 | medulloblastoma | 0.7957650276957399 | ||
| O43766 | LIAS | Lipoyl synthase, mitochondrial | Tier 1 | 0.589 | 1 | B_cargo | 5 | 81.19 | 0 | 0 | 1 | 1 | 32329602 | 0 | lipoic acid synthetase deficiency | 0.7951307244152087 | ||
| O14770 | MEIS2 | Homeobox protein Meis2 | Tier 1.5 | 0.588 | 1 | B_cargo | 4 | 61.97 | 0 | 0 | 1 | 2 | 41495882 | 0 | cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies | 0.7938323593532864 | ||
| P05129 | PRKCG | Protein kinase C gamma type | Tier 1 | 0.587 | 1 | B_cargo | 2 | 81.44 | 0 | 0 | 1 | 1 | 33334063 | 0 | spinocerebellar ataxia type 14 | 0.7904034101945372 | ||
| P46527 | CDKN1B | Cyclin-dependent kinase inhibitor 1B | Tier 1 | 0.587 | 1 | B_cargo | 19 | 69.25 | 1 | 0 | 1 | 1 | 20191379 | 0 | multiple endocrine neoplasia type 4 | 0.7896116263348134 | ||
| P49711 | CTCF | Transcriptional repressor CTCF | Tier 1 | 0.587 | 1 | B_cargo | 21 | 58.81 | 1 | 0 | 1 | 5 | 41955940, 41430607, 35927613, 31288216, 20435085 | 0 | CTCF-related neurodevelopmental disorder | 0.7903743707735115 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;